Forward P/S Multiple: Sensus Healthcare (SRTS)
Sensus Healthcare, Inc. (SRTS) leads the development of mobile X-ray systems for combating non-melanoma skin cancer. The expected P/S ratio allows for a real-time assessment of revenue forecasts, while 3.00 expresses the current value of the metric. Sensus Healthcare, Inc. (SRTS) possesses pricing power within its niche, although clinic budgets limit cost growth. Specialized medical logistics ensure system reliability during transportation.
Summary analytical data breakdowns for Sensus (SRTS)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital Sensus Healthcare, Inc.|SRTS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Sensus Healthcare, Inc.|SRTS - Company Aggregate Debts|Debt to Book Capitalization Ratio Sensus|SRTS - Company Long-Term Debt|Company Current Liabilities Sensus Healthcare|Quick Ratio sensushealthcare.com
- financial results and valuation multiples details:
SRTS - Company Net Income|Expected Profit Sensus Healthcare, Inc.|SRTS - Market Cap to Net Income Ratio|Projected Price to Earnings Sensus Healthcare Corp|SRTS - PEG Multiple|EV/EBITDA Multiple Sensus|SRTS - Operating income before deduction of amortization|Earnings per share for the last twelve months Sensus Healthcare|SRTS - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months sensushealthcare.com|SRTS - Net earnings per share growth this year|Earnings growth forecast for next year Sensus Healthcare, Inc.
- sales and revenue indicators:
Fundamental company analysis:SRTS (Sensus Healthcare)
For an investor in Sensus Healthcare, Inc. (SRTS), the fundamental valuation of the company within the context of its market positioning requires an analysis of expected cash flows. The forward P/S metric correlates market capitalization with projected revenue, allowing an assessment via this curve of how effectively partnerships with oncology clinics to implement radiation therapy systems are converted into the business's market value.
Who Sensus Healthcare, Inc. competes with
Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio lensar.com LNSR|Price-to-Projected Revenue Ratio AVITA Medical (RCEL)|profoundmedical.com (PROF) - Projected Price to Revenue|Baird Medical - Forward Price-to-Revenue Multiple|Forward P/S Multiple EDAP TMS SA EDAP|Bovie Medical - Forward P/S Multiple|Market Cap to Expected Sales Ratio IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Price-to-Projected Revenue Ratio|Future Price to Revenue TELA (TELA Bio)|Price-to-Projected Revenue Ratio CytoSorbents Corp|Forward Price-to-Revenue Multiple Zynex Corp (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Projected Revenue|IRIX: Forward Price-to-Revenue Multiple|Intelligent Bio Solutions - Price to Expected Revenue Ratio|beyondair.net (XAIR) - Price-to-Projected Revenue Ratio|PFSA - Market Cap to Expected Sales Ratio|SSKN (STRATA Skin Sciences Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio glucotrack.com GCTK|Price-to-Projected Revenue Ratio NanoVibronix (NAOV)|Venus Concept Corporation - Market Cap to Projected Revenue|Price-to-Projected Revenue Ratio Nuwellis, Inc. NUWE|Market Cap to Expected Sales Ratio aethlonmedical.com (AEMD)|ASXC: Forward Price-to-Revenue Multiple|AVGR - Forward P/S Multiple|BioSig Technologies, Inc (BSGM) - Price-to-Projected Revenue Ratio|CUTR - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple KNW|NARI: Forward Price to Sales|Forward P/S Multiple NVRO|RSLS (reshapelifesciences.com) - Forward Price to Sales|Forward P/S Multiple SILK (Silk Road Medical Inc.)
